Dashboard
Manage Tickers

ALRNAILERON THERAPEUTICS INC

Nasdaq aileronrx.com


$ 3.89 $ 0.00 (0 %)    

Wednesday, 15-May-2024 15:58:16 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 453.26 $ -0.35 (-0.08 %)
DIA $ 399.31 $ 3.70 (0.94 %)
SPY $ 530.18 $ 6.48 (1.24 %)
TLT $ 92.14 $ 1.24 (1.36 %)
GLD $ 220.89 $ 2.80 (1.28 %)
$ 3.9
$ 3.83
$ 0.00 x 0
$ 0.00 x 0
$ 3.79 - $ 3.90
$ 1.01 - $ 7.42
20,862
na
32.38M
$ 1.55
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 04-15-2024 12-31-2023 10-K
3 10-13-2023 09-30-2023 10-Q
4 08-11-2023 06-30-2023 10-Q
5 05-08-2023 03-31-2023 10-Q
6 03-20-2023 12-31-2022 10-K
7 11-01-2022 09-30-2022 10-Q
8 08-15-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-28-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-24-2021 12-31-2020 10-K
15 11-12-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-30-2020 12-31-2019 10-K
19 11-07-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-29-2019 12-31-2018 10-K
23 11-07-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-09-2018 03-31-2018 10-Q
26 04-02-2018 12-31-2017 10-K
27 11-09-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 02-14-2013 12-31-2012 10-Q
30 11-14-2012 09-30-2012 10-Q
31 08-13-2012 06-30-2012 10-Q
32 06-22-2012 03-31-2012 10-K
33 02-14-2012 12-31-2011 10-Q
34 11-14-2011 09-30-2011 10-Q
35 08-12-2011 06-30-2011 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

aileron-therapeutics-q1-2024-gaap-eps-086-misses-014-estimate
Aileron Therapeutics Q1 2024 GAAP EPS $(0....
05/15/2024 21:13:49

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate o...

aileron-therapeutics-prices-4273505-offering-of-shares-and-accompanying-warrants-at-combined-offering-price-of-468
Aileron Therapeutics Prices 4,273,505 Offe...
05/01/2024 12:56:30

aileron-therapeutics-announces-data-from-cohort-1-of-phase-1b-clinical-trial-of-lti-03-in-idiopathic-pulmonary-fibrosis
Aileron Therapeutics Announces Data From C...
05/01/2024 12:33:47

Low-dose LTI-03 (2.5 mg BID), a Caveolin-1 related peptide, reduced expression of multiple profibrotic proteins in both patholo...

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
04/18/2024 16:31:41

aileron-therapeutics-filed-us-patent-application-20240124518-methods-for-preparing-purified-polypeptide-compositions
Aileron Therapeutics Filed U.S. Patent App...
04/18/2024 15:50:01

https://ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20240124518

why-las-vegas-sands-shares-are-trading-lower-by-around-7-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Las Vegas Sands Shares Are Trading Low...
04/18/2024 15:32:50

ladenburg-thalmann-maintains-buy-on-aileron-therapeutics-raises-price-target-to-19
Ladenburg Thalmann Maintains Buy on Ailero...
04/18/2024 12:36:37

Ladenburg Thalmann analyst Aydin Huseynov maintains Aileron Therapeutics (NASDAQ:ALRN) with a Buy and raises the price targe...

aileron-therapeutics-q4-eps-154-down-from-100-yoy-cash-runway-expected-to-fund-operations-and-key-milestones-into-q4-of-2024
Aileron Therapeutics Q4 EPS $(1.54) Down F...
04/15/2024 21:24:29

Aileron Therapeutics (NASDAQ:ALRN) reported quarterly losses of $(1.54) per share versus losses of $(1.00) per share from the s...

aileron-therapeutics-has-appointed-brian-windsor-current-president-and-chief-operating-officer-as-president-and-ceo-effective-march-11-2024-succeeding-manuel-aivado-who-has-stepped-down-as-ceo-and-will-continue-to-serve-on-board-of-directors
Aileron Therapeutics Has Appointed Brian W...
03/12/2024 12:08:11

on-feb-29-aileron-therapeutics-got-letter-from-nasdaq-that-co-has-regained-compliance-for-continued-listing-on-nasdaq
On Feb 29, Aileron Therapeutics Got Letter...
03/01/2024 21:16:36

- SEC Filing

aileron-therapeutics-and-pulmonary-care-experts-to-discuss-the-potential-implications-of-lti-03-for-idiopathic-pulmonary-fibrosis-in-virtual-key-opinion-leader-event
Aileron Therapeutics And Pulmonary Care Ex...
02/15/2024 21:40:37

Aileron Therapeutics, Inc. ("Aileron") (NASDAQ:ALRN), a biopharmaceutical company advancing a novel pipeline of first-i...

why-ups-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why UPS Shares Are Trading Lower By 8%? He...
01/30/2024 18:18:27

Shares of United Parcel Service, Inc. (NYSE: UPS) fell sharply during Tuesday’s session after the company reported worse-than-e...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
01/23/2024 21:31:04

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
01/12/2024 13:05:59

why-quanex-building-products-shares-are-trading-lower-by-over-10-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Quanex Building Products Shares Are Tr...
12/15/2023 17:46:24

Shares of Quanex Building Products Corporation (NYSE: NX) moved lower during Friday’s session after the company reported fourth...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
12/15/2023 17:31:25

why-getaround-shares-are-trading-higher-by-around-86-here-are-20-stocks-moving-premarket
Why Getaround Shares Are Trading Higher By...
12/15/2023 13:17:09

Shares of Getaround, Inc. (NYSE: GETR) rose sharply in pre-market trading after the company reported a year-over-year increas...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
12/15/2023 13:08:05

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 21:31:15

ladenburg-thalmann-upgrades-aileron-therapeutics-to-buy-announces-9-price-target
Ladenburg Thalmann Upgrades Aileron Therap...
12/01/2023 16:43:37

Ladenburg Thalmann analyst Aydin Huseynov upgrades Aileron Therapeutics (NASDAQ:ALRN) from Neutral to Buy and announces $9 p...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION